​

Caribou Biosciences (CRBU) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

CRBU Stock Forecast

Caribou Biosciences (CRBU) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $3.00, with a high of $3.00 and a low of $3.00. This represents a 158.62% increase from the last price of $1.16.

$1 $2 $3 $4 $5 $6 $7 $8 High: $3 Avg: $3 Low: $3 Last Closed Price: $1.16

CRBU Stock Rating

Caribou Biosciences stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 8 Strong Sell Sell Hold Buy Strong Buy

CRBU Price Target Upside V Benchmarks

TypeNameUpside
StockCaribou Biosciences158.62%
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.16$1.16$1.16
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25252--9
May, 25252--9
Apr, 25252--9
Mar, 25252--9
Feb, 25252--9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 03, 2024Liisa BaykoEvercore ISI$3.00$2.884.17%158.62%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 28, 2025H.C. WainwrightBuyBuyhold
Sep 04, 2024H.C. WainwrightBuyBuyhold
Aug 14, 2024RBC CapitalBuyBuyhold
Jul 17, 2024H.C. WainwrightBuyBuyhold
Jun 04, 2024H.C. WainwrightBuyBuyhold
Jun 03, 2024CitigroupBuyBuyhold
May 16, 2024RBC CapitalBuyBuyhold
Feb 18, 2022RBC CapitalOutperforminitialise
Nov 30, 2021H.C. WainwrightBuyinitialise

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.11$-1.64$-1.38$-1.65----
Avg Forecast$-2.12$-1.69$-1.37$-1.66$-1.86$-1.95$-2.39$-1.17
High Forecast$-0.97$-1.42$-1.19$-1.50$-1.37$-1.32$-1.19$-0.98
Low Forecast$-3.07$-2.19$-1.47$-1.74$-3.04$-2.68$-3.80$-1.51
Surprise %-47.64%-2.96%0.73%-0.60%----

Revenue Forecast

$0 $90M $180M $270M $360M $450M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.60M$13.85M$34.48M-----
Avg Forecast$10.94M$12.43M$34.90M$10.26M$10.14M$28.18M$51.75M$330.94M
High Forecast$14.69M$15.27M$38.69M$11.93M$12.45M$34.60M$63.56M$406.41M
Low Forecast$6.39M$10.90M$33.29M$8.25M$8.90M$24.72M$45.40M$290.30M
Surprise %-12.27%11.42%-1.23%-----

Net Income Forecast

$-300M $-250M $-200M $-150M $-100M $-50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-66.92M$-99.42M$-102.07M$-149.10M----
Avg Forecast$-156.59M$-124.81M$-102.07M$-119.42M$-195.12M$-147.87M$-267.57M$-85.99M
High Forecast$-71.93M$-104.88M$-87.62M$-110.46M$-100.99M$-97.63M$-87.83M$-72.26M
Low Forecast$-226.35M$-161.81M$-108.59M$-128.37M$-224.34M$-198.11M$-280.47M$-111.48M
Surprise %-57.26%-20.34%-24.86%----

CRBU Forecast FAQ

Is Caribou Biosciences stock a buy?

Caribou Biosciences stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Caribou Biosciences is a favorable investment for most analysts.

What is Caribou Biosciences's price target?

Caribou Biosciences's price target, set by 8 Wall Street analysts, averages $3 over the next 12 months. The price target range spans from $3 at the low end to $3 at the high end, suggesting a potential 158.62% change from the previous closing price of $1.16.

How does Caribou Biosciences stock forecast compare to its benchmarks?

Caribou Biosciences's stock forecast shows a 158.62% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for Caribou Biosciences over the past three months?

  • June 2025: 22.22% Strong Buy, 55.56% Buy, 22.22% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 22.22% Strong Buy, 55.56% Buy, 22.22% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 22.22% Strong Buy, 55.56% Buy, 22.22% Hold, 0% Sell, 0% Strong Sell.

What is Caribou Biosciences’s EPS forecast?

Caribou Biosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.86, marking a 12.73% increase from the reported $-1.65 in 2024. Estimates for the following years are $-1.95 in 2026, $-2.39 in 2027, and $-1.17 in 2028.

What is Caribou Biosciences’s revenue forecast?

Caribou Biosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $10.14M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $28.18M, followed by $51.75M for 2027, and $330.94M for 2028.

What is Caribou Biosciences’s net income forecast?

Caribou Biosciences's net income forecast for the fiscal year ending in December 2025 stands at $-195M, representing an 30.86% increase from the reported $-149M in 2024. Projections indicate $-148M in 2026, $-268M in 2027, and $-85.986M in 2028.